Commercial funding and authors’ financial ties are common in clinical trials. Previously, there has been little guidance on how to address such conflicts of interest when conducting systematic reviews.
The Tool for Addressing Conflicts of Interest in Trials (TACIT) provides systematic reviewers with a framework for addressing conflicts of interest in trials included in Cochrane Reviews and other systematic reviews. This Cochrane Learning Live webinar outlined the development and practical use of the tool.
The session was open to everyone, and of particular interest to systematic reviewers, Cochrane editors and other people involved in developing systematic reviews, including Cochrane Reviews.
The session was delivered in February 2026 and below you will find the recording with the accompanying slides to download [PDF].
Visit www.tacit.one for more information about the tool.
Presenter Bios
Andreas Lundh is a meta-researcher, and the focus of his research is on how conflicts of interest may influence the design, conduct, analysis and reporting of clinical research. He is co-leading the development of TACIT.
Asbjørn Hróbjartsson is professor of Evidence-Based Medicine and Clinical Research Methodology. The focus of his research is on the quality of clinical research, especially systematic reviews, and clinical trials. He has an interest in ways to assess and minimise bias in clinical studies. He is co-leading the development of TACIT.
